CRDF EPS Estimates
Cardiff Oncology, Inc.
$0.97
-$0.04(-3.62%)
35
Overall
60
Value
10
Tech
36
Quality
Market Cap
$75.73M
Volume
412.91K
52W Range
$0.76 - $3.31
Target Price
$6.28
CRDF EPS estimates: the consensus estimate for Cardiff Oncology, Inc.'s current fiscal year is -$0.60 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRDF EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.15
- EPS estimate, current year
- $-0.60
- EPS estimate, next year
- $-0.56
- EPS growth, 3-year
- +8.13%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.69 |
| 2024 | $-0.95 |
| 2023 | $-0.93 |
| 2022 | $-0.89 |
| 2021 | $-0.73 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRDF | $0.97 | -3.6% | 412.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |